Company Info General Information Company Snapshot Company Background Company History Company News Share Price Smart Quotes Historical Prices Charting Monthly Share Prices Company Details Board of Directors Shareholding Pattern Branches Product Details Compare Company Peer Group Comparison Financial Summary Results P&L Account Balance Sheet Cash Flows Key Financial Ratios Valuation Ratio Financial Ratios Scoreboard Earnings Investor Information Dividend History Chairman's Speech Directors Report Fo. Board Meeting Corporate Action Announcements BM - Book Closure Bonus - Rights - Split De-listed Shares Market Turnover Change of Name Equity History Latest Equity Equity History Bonus History MF Holdings Deliverable Volumes Enter Symbol Detailed Quote Company Snapshot Company Background Company History Company News Smart Quotes Historical Prices Charting Monthly Share Prices Board Of Directors Share Holding Branches Products Compare company Peer Group Results P &L Account Balance Sheet Cash Flows Valuation Ratio Financial Ratios Scoreboard Earnings Dividend History Chairman's Speech Directors Report Fo.Board Meeting Announcements Book Closure Bonus - Rights De-listed Shares Market Turnover Change of Name Latest Equity Equity History Bonus History MF Holdings Delivery Volumes Symbol Lookup Brawn Pharmaceuticals Ltd Chairman :   B R Gupta Industry :  Pharmaceuticals - Indian - Formulations BSE Code  530207 Bid  0.00 P / E  10.78 ISIN Demat  INE899B01015 Offer  16.50 Eps  1.53 Book Value  11.73 Volume  8,735 Market Lot  1 Div & Yield %  0.00 Market Cap  4.95 Face Value  10 No Data  Company Background | Balance Sheet | Financial Ratios | Forthcoming Board Meetings | Dividend History Share Price Smart Quotes Historical Prices Charting Monthly Share Prices No Data Available NSEBSE 1 Day 5 Day 3 Mon 1 Yr 5 Yrs Advanced Charting   Peer Comparison Compare Company       Segment of Trade : A Book Closure Period Purpose From Purpose Segment of Trade : EQ Book Closure Period Purpose From: To: --/--   Latest News More Headlines Aug 13,2010 12:00:00 AM Brawn Pharmaceuticals net profit rises 2050.00% in the June 2010 quarter May 11,2010 12:00:00 AM Brawn Pharmaceuticals reports nil net profit/loss in the March 2010 quarter

Privacy|Disclaimer|Contact Us|Career|Site Map| Home | About Us SEBI NSE BSE NSDL CDSL NCDEX MCX Stock Market | Online Share Trading | Depository Services | Mutual Fund Schemes | IPO Investment | Stock Research| Investor Complaints  NSE  -  SEBI Registration No : Equity - INB 230825534  , F&O - INF 231053936   BSE  -  SEBI Registration No  :  Equity - INB 011347037 , F&O - INF 011347037 SEBI Registration No: MCX-SX - INE261053936 ; NSE CDS: INE231053936 Member Id: MCX-SX - 49400 ; NSE CDS : 10539  FMC Registration number for   MCX - MCX/TCM/CORP/0023,  FMC Registration number for NCDEX - NCDEX/TCM/CORP/0180  MCX Member ID - 28730, NCDEX Member ID - 00158  Designed, developed and content provided by CMOTS Infotech (ISO 9001:2000 certified) CopyRight (c) Reserved 2002 Apollo Sindhoori Capital Investments Ltd